文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

老年终末期筛查工具对老年患者6个月死亡率的预测

Geriatric End-of-Life Screening Tool Prediction of 6-Month Mortality in Older Patients.
PubMed 文献 · JAMA Netw Open · 2024-05-01
一句话结论在急诊老年患者中,GEST算法预测6个月死亡率的AUC为0.79,决策曲线分析优于严重疾病诊断标准,未来干预试验可考虑从诊断编码标准转向GEST。

该预后研究在波士顿一家三级急诊科2017至2021年82371次就诊、40505名65岁以上患者中外部验证GEST(基于电子健康记录数据的逻辑回归算法),并与严重疾病诊断标准比较。主要终点为急诊就诊后6个月死亡率(13.8%)。GEST的AUC为0.79(95%CI 0.78-0.79),在各年份和人口亚组中稳定;GEST将45.1%的严重疾病患者重分类为低死亡风险(观察死亡率8.1%),将2.6%的无严重疾病患者重分类为高死亡风险(观察死亡率34.3%),总重分类率25.3%,决策曲线分析在所有测试阈值上优于严重疾病标准。作者认为未来针对高死亡风险老年人的严重疾病干预试验可考虑从诊断编码标准转向GEST。

要点

  • GEST外部验证AUC为0.79(95%CI 0.78-0.79),在各年份和人口亚组中稳定。
  • GEST阈值从5%升至30%时,特异性从49.1%升至92.2%,敏感性从89.3%降至36.2%。
  • 决策曲线分析中GEST在所有测试阈值上优于严重疾病诊断标准。
  • GEST将45.1%的严重疾病患者重分类为低死亡风险(观察死亡率8.1%),将2.6%的无严重疾病患者重分类为高死亡风险(观察死亡率34.3%),总重分类率25.3%。

适用人群与场景

  • 年龄65岁及以上、在波士顿一家三级急诊科就诊的患者,就诊时间2017至2021年。
  • 排除心脏骤停到达或急诊到达后1天内死亡的患者。

诊断标准与关键阈值

  • GEST为逻辑回归算法,使用常规可获取的电子健康记录数据点。
  • 严重疾病诊断标准包括卒中/短暂性脑缺血发作、肝病、癌症、肺病和年龄大于80岁等。

研究设计与关键结果

  • 研究类型为预后研究(外部验证),纳入82371次急诊就诊、40505名独立个体,平均年龄76.8岁(SD 8.4),女性54.3%,6个月死亡率为13.8%。
  • GEST外部验证AUC为0.79(95%CI 0.78-0.79),在各年份和人口亚组中稳定。
  • 53.4%的就诊有严重疾病,其敏感性为77.4%(95%CI 76.6%-78.2%),特异性为50.5%(95%CI 50.1%-50.8%)。
  • GEST阈值5%时特异性49.1%(95%CI 48.7%-49.5%)、敏感性89.3%(95%CI 88.8-89.9);阈值30%时特异性92.2%(95%CI 92.0%-92.4%)、敏感性36.2%(95%CI 35.3-37.1)。
  • 决策曲线分析中GEST在所有测试阈值上优于严重疾病标准。
  • 与严重疾病标准相比,GEST将45.1%的严重疾病患者重分类为低死亡风险(观察死亡率8.1%),将2.6%的无严重疾病患者重分类为高死亡风险(观察死亡率34.3%),总重分类率25.3%。

证据类型、等级与局限

  • 证据类型:预后研究(外部验证)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,未来针对高死亡风险老年人的严重疾病干预试验可考虑从诊断编码标准转向GEST这一可自动化的电子健康记录算法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Emergency department (ED) visits by older adults with life-limiting illnesses are a critical opportunity to establish patient care end-of-life preferences, but little is known about the optimal screening criteria for resource-constrained EDs.

OBJECTIVES: To externally validate the Geriatric End-of-Life Screening Tool (GEST) in an independent population and compare it with commonly used serious illness diagnostic criteria.

DESIGN, SETTING, AND PARTICIPANTS: This prognostic study assessed a cohort of patients aged 65 years and older who were treated in a tertiary care ED in Boston, Massachusetts, from 2017 to 2021. Patients arriving in cardiac arrest or who died within 1 day of ED arrival were excluded. Data analysis was performed from August 1, 2023, to March 27, 2024.

EXPOSURE: GEST, a logistic regression algorithm that uses commonly available electronic health record (EHR) datapoints and was developed and validated across 9 EDs, was compared with serious illness diagnoses as documented in the EHR. Serious illnesses included stroke/transient ischemic attack, liver disease, cancer, lung disease, and age greater than 80 years, among others.

MAIN OUTCOMES AND MEASURES: The primary outcome was 6-month mortality following an ED encounter. Statistical analyses included area under the receiver operating characteristic curve, calibration analyses, Kaplan-Meier survival curves, and decision curves.

RESULTS: This external validation included 82 371 ED encounters by 40 505 unique individuals (mean [SD] age, 76.8 [8.4] years; 54.3% women, 13.8% 6-month mortality rate). GEST had an external validation area under the receiver operating characteristic curve of 0.79 (95% CI, 0.78-0.79) that was stable across years and demographic subgroups. Of included encounters, 53.4% had a serious illness, with a sensitivity of 77.4% (95% CI, 76.6%-78.2%) and specificity of 50.5% (95% CI, 50.1%-50.8%). Varying GEST cutoffs from 5% to 30% increased specificity (5%: 49.1% [95% CI, 48.7%-49.5%]; 30%: 92.2% [95% CI, 92.0%-92.4%]) at the cost of sensitivity (5%: 89.3% [95% CI, 88.8-89.9]; 30%: 36.2% [95% CI, 35.3-37.1]). In a decision curve analysis, GEST outperformed serious illness criteria across all tested thresholds. When comparing patients referred to intervention by GEST with serious illness criteria, GEST reclassified 45.1% of patients with serious illness as having low risk of mortality with an observed mortality rate 8.1% and 2.6% of patients without serious illness as having high mortality risk with an observed mortality rate of 34.3% for a total reclassification rate of 25.3%.

CONCLUSIONS AND RELEVANCE: The findings of this study suggest that both serious illness criteria and GEST identified older ED patients at risk for 6-month mortality, but GEST offered more useful screening characteristics. Future trials of serious illness interventions for high mortality risk in older adults may consider transitioning from diagnosis code criteria to GEST, an automatable EHR-based algorithm.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Haimovich AD, Burke RC, Nathanson LA, et al. Geriatric End-of-Life Screening Tool Prediction of 6-Month Mortality in Older Patients. JAMA Netw Open. 2024. PMID: 38819823. doi:10.1001/jamanetworkopen.2024.14213

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。